Showing results (111-120 of 129) with videos related to
Sort By:
Pageof 13
Journal of Medical Genetics|September 30, 2020
Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspectiveHuahua Zhong, Yiming Zheng, Zhe Zhao, et al.Multiple Sclerosis and Related Disorders|December 10, 2020
Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experienceWenjuan Huang, Jingzi ZhangBao, Xuechun Chang, et al.Frontiers in Immunology|June 8, 2026
Patient preferences and willingness-to-pay for therapy in generalized myasthenia gravis: a large-scale discrete choice experiment in ChinaYafang Xu, Ling Feng, Mingjie Zhang, et al.European Journal of Neurology|April 10, 2022
Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorderWenjuan Huang, Liang Wang, Junhui Xia, et al.Therapeutic Advances in Neurological Disorders|September 2, 2017
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in ChinaLei Zhou, Weibin Liu, Wei Li, et al.Muscle & Nerve|April 1, 2024
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopeniaKexin Jiao, Nachuan Cheng, Xiao Huan, et al.Orphanet Journal of Rare Diseases|March 8, 2024
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1Huahua Zhong, Li Zeng, Xuefan Yu, et al.Brain : a Journal of Neurology|December 29, 2020
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathyJianying Xi, Xilu Wang, Dongyue Yue, et al.The Journal of Molecular Diagnostics : JMD|March 20, 2025
4qA D4Z4 Methylation Test as a Valuable Complement for Differential Diagnosis in Patients with a Facioscapulohumeral Muscular Dystrophy-Like PhenotypeXingyu Xia, Nachuan Cheng, Yiqi Liu, et al.EMBO Molecular Medicine|October 15, 2025
Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagyAng Li, Sen Huang, Shu-Qin Cao, et al.Pageof 13